Aarti Drugs Ltd (nse:AARTIDRUGS) Share Price

Company Profile

Business description
Aarti Drugs Ltd is engaged in the business of manufacturing and marketing finished pharmaceutical formulations. The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and speciality chemicals, with products spanning therapeutic segments that include antibiotic, antiprotozoal, anti-inflammatory, antidiabetic, and antifungal therapies. The operations of the Company are limited to one segment, i.e., manufacturing of API (Active Pharmaceutical Ingredients). The Company operates in India and outside India, with India generating the maximum revenue.
Contact
Road No. 29, Plot Number 109-D
Mahendra Industrial Estate, Ground Floor
Sion (East)
MumbaiMH400022
IND
T: +91 2224019025
https://www.aartidrugs.co.in
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
2,831

Recommended

We see regulatory risk from both the US and Chinese governments.

Seth Goldstein, CFA | 25 October 2026

Near-term pain, long-term potential.

Dan Baker | 22 October 2026

We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.

Malik Ahmed Khan, CFA | 22 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,926.60	20.80	0.23%
CAC 40	7,861.19	78.37	1.01%
DAX 40	25,488.50	306.85	1.22%
Dow JONES (US)	52,459.33	244.17	0.47%
FTSE 100	10,762.30	71.94	0.67%
HKSE	23,211.81	118.44	0.51%
NASDAQ	26,272.54	317.20	1.22%
Nikkei 225	62,189.65	503.51	-0.80%
NZX 50 Index	13,733.93	12.91	-0.09%
S&P 500	7,695.18	71.50	0.94%
S&P/ASX 200	8,809.90	14.70	0.17%
SSE Composite Index	3,697.52	7.04	0.19%